Modern pharmacotherapy of urge urinary incontinence in the USA: tolterodine and oxybutynin
Open Access
- 1 October 2000
- journal article
- research article
- Published by Wiley in BJU International
- Vol. 86 (s2) , 44-54
- https://doi.org/10.1046/j.1464-410x.2000.00097.x
Abstract
No abstract availableKeywords
This publication has 47 references indexed in Scilit:
- Treatment of detrusor instability with oxybutynin rectal suppositoriesInternational Urogynecology Journal, 1998
- Efficacy and safety of tolterodine in patients with detrusor instability: a dose‐ranging studyBritish Journal of Urology, 1998
- Antimuscarinic Potency and Bladder Selectivity of PNU‐200577, a Major Metabolite of TolterodineBasic & Clinical Pharmacology & Toxicology, 1997
- Tolterodine-a new bladder selective muscarinic receptor antagonist: Preclinical pharmacological and clinical dataLife Sciences, 1997
- Urodynamic and other effects of tolterodine: A novel antimuscarinic drug for the treatment of detrusor overactivityNeurourology and Urodynamics, 1995
- Antimuscarinic activity of telenzepine on isolated human urinary bladder: No role for m1-muscarinic receptorsGeneral Pharmacology: The Vascular System, 1992
- Efficacy of bladder training in older women with urinary incontinencePublished by American Medical Association (AMA) ,1991
- The molecular basis of muscarinic receptor diversityTrends in Neurosciences, 1989
- Current Concepts in the Treatment of Disorders of MicturitionDrugs, 1988
- Identification and characterization of muscarinic cholinergic receptors in the human urinary bladder and parotid glandJournal of the Autonomic Nervous System, 1987